125 related articles for article (PubMed ID: 7705954)
1. Anti-gastrin antibodies raised by gastrimmune inhibit growth of the human colorectal tumour AP5.
Watson SA; Michaeli D; Grimes S; Morris TM; Crosbee D; Wilkinson M; Robinson G; Robertson JF; Steele RJ; Hardcastle JD
Int J Cancer; 1995 Apr; 61(2):233-40. PubMed ID: 7705954
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer.
Smith AM; Justin T; Michaeli D; Watson SA
Clin Cancer Res; 2000 Dec; 6(12):4719-24. PubMed ID: 11156225
[TBL] [Abstract][Full Text] [Related]
3. Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LV.
Watson SA; Michaeli D; Morris TM; Clarke P; Varro A; Griffin N; Smith A; Justin T; Hardcastle JD
Eur J Cancer; 1999 Aug; 35(8):1286-91. PubMed ID: 10615243
[TBL] [Abstract][Full Text] [Related]
4. Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer.
Watson SA; Michaeli D; Grimes S; Morris TM; Robinson G; Varro A; Justin TA; Hardcastle JD
Cancer Res; 1996 Feb; 56(4):880-5. PubMed ID: 8631028
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of the gastrin receptor antagonist CR2093 on basal, gastrin-stimulated and growth factor-stimulated growth of the rat pancreatic cell line AR42J.
Watson SA; Clifford TL; Steele RJ
Anticancer Drugs; 1994 Oct; 5(5):591-7. PubMed ID: 7858292
[TBL] [Abstract][Full Text] [Related]
6. A comparison of an anti-gastrin antibody and cytotoxic drugs in the therapy of human gastric ascites in SCID mice.
Watson SA; Michaeli D; Grimes S; Morris TM; Varro A; Clarke PA; Smith AM; Justin TA; Hardcastle JD
Int J Cancer; 1999 Apr; 81(2):248-54. PubMed ID: 10188727
[TBL] [Abstract][Full Text] [Related]
7. Intracellular gastrin in human gastrointestinal tumor cells.
Watson SA; Durrant LG; Wencyk PM; Watson AL; Morris DL
J Natl Cancer Inst; 1991 Jun; 83(12):866-71. PubMed ID: 2061947
[TBL] [Abstract][Full Text] [Related]
8. Gastrimmune-induced antigastrin-17 antibodies inhibit acid secretion in a rat fistula model.
Smith AM; Morris T; Justin T; Michaeli D; Watson SA
Aliment Pharmacol Ther; 2001 Dec; 15(12):1981-8. PubMed ID: 11736730
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evaluation of the Gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model.
Watson SA; Michael D; Justin TA; Grimes S; Morris TM; Robinson G; Clarke PA; Hardcastle JD
Int J Cancer; 1998 Mar; 75(6):873-7. PubMed ID: 9506532
[TBL] [Abstract][Full Text] [Related]
10. Gastrin 17 vaccine--Aphton: Anti-gastrin 17 immunogen, G17DT.
BioDrugs; 2003; 17(3):223-5. PubMed ID: 12749761
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the therapeutic effectiveness of gastrin neutralisation in two human gastric cancer models: relation to endocrine and autocrine/paracrine gastrin mediated growth.
Watson SA; Morris TM; Varro A; Michaeli D; Smith AM
Gut; 1999 Dec; 45(6):812-7. PubMed ID: 10562577
[TBL] [Abstract][Full Text] [Related]
12. Cell type-specific requirement of the MAPK pathway for the growth factor action of gastrin.
Stepan VM; Dickinson CJ; del Valle J; Matsushima M; Todisco A
Am J Physiol; 1999 Jun; 276(6):G1363-72. PubMed ID: 10362639
[TBL] [Abstract][Full Text] [Related]
13. Phage display selection of fully human antibody fragments to inhibit growth-promoting effects of glycine-extended gastrin 17 on human colorectal cancer cells.
Khajeh S; Tohidkia MR; Aghanejad A; Mehdipour T; Fathi F; Omidi Y
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):1082-1090. PubMed ID: 29886758
[TBL] [Abstract][Full Text] [Related]
14. [Gastrin-17 and G17-gly induce proliferation of LoVo cells through the CCK B/gastrin receptor].
Artru P; Attoub S; Levasseur S; Lewin MJ; Bado A
Gastroenterol Clin Biol; 1998; 22(6-7):607-12. PubMed ID: 9762332
[TBL] [Abstract][Full Text] [Related]
15. Antibodies raised against the extracellular tail of the CCKB/gastrin receptor inhibit gastrin-stimulated signalling.
McWilliams DF; Grimes S; Watson SA
Regul Pept; 2001 Jun; 99(2-3):157-61. PubMed ID: 11384777
[TBL] [Abstract][Full Text] [Related]
16. rG17PE38, a novel immunotoxin target to gastric cancer with overexpressed CCK-2R.
Song J; Ren H; Li Y; Xu J; Kong H; Tong W; Zhou Y; Gao S; Liu Y; Hui Q; Peng Q; Lu S; Liu Z
J Drug Target; 2013 May; 21(4):375-82. PubMed ID: 23311704
[TBL] [Abstract][Full Text] [Related]
17. High and low affinity receptors mediate growth effects of gastrin and gastrin-Gly on DLD-1 human colonic carcinoma cells.
Ahmed S; Budai B; Herédi-Szabó K; Farkas J; Tóth G; Murphy RF; Lovas S
FEBS Lett; 2004 Jan; 556(1-3):199-203. PubMed ID: 14706850
[TBL] [Abstract][Full Text] [Related]
18. Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Watson SA; Smith AM
Cancer Res; 2001 Jan; 61(2):625-31. PubMed ID: 11212260
[TBL] [Abstract][Full Text] [Related]
19. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
[TBL] [Abstract][Full Text] [Related]
20. Anti-Gastrins Antiserum Combined with Lowered Dosage Cytotoxic Drugs to Inhibit the Growth of Human Gastric Cancer SGC7901 Cells in Nude Mice.
He Q; Gao H; Gao M; Qi S; Zhang Y; Wang J
J Cancer; 2015; 6(5):448-56. PubMed ID: 25874008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
